Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 229Lymphoma 30Hematologic Neoplasms 21Recurrence 17Neoplasms 14Neoplasms, Plasma Cell 13Immunoglobulin Light-chain Amyloidosis 13Lymphoma, Non-Hodgkin 12Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia, Myeloid, Acute 10Lymphoma, Mantle-Cell 9Smoldering Multiple Myeloma 8Prostatic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic Syndromes 8Lymphoma, Large B-Cell, Diffuse 8Hodgkin Disease 8Ovarian Neoplasms 6Lung Neoplasms 6Leukemia, Plasma Cell 6Breast Neoplasms 6Waldenstrom Macroglobulinemia 5Melanoma 5Lymphoma, Follicular 5Monoclonal Gammopathy of Undetermined Significance 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhagic Disorders × Plasma cell × 30 days × Clear all
NCT06963216 2026-05-11

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

Kedrion S.p.A.

Phase 3 Recruiting
15 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Blood Coagulation Disorders, Factor X Deficiency, Hematologic Diseases, Hemorrhagic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡